MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

14 May 2024 Evaluate
The turnover zoomed to Rs. 420.11 millions, up 52.30% for the March 2024 quarter as against Rs. 275.85 millions during the year-ago period.Net Profit recorded in the quarter ended March 2024 rise to 35.88% to Rs. 158.86  millions  compared to R. 116.91 millions in corresponding previous quarter.Operating profit surged to 219.49 millions from the corresponding previous quarter of 163.24 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 420.11 275.85 52.30 1698.22 1483.85 14.45 1698.22 1483.85 14.45
Other Income 10.18 19.62 -48.11 43.66 65.88 -33.73 43.66 65.88 -33.73
PBIDT 219.49 163.24 34.46 831.00 802.17 3.59 831.00 802.17 3.59
Interest 0.75 0.25 200.00 2.29 1.76 30.11 2.29 1.76 30.11
PBDT 218.74 162.99 34.20 828.71 800.41 3.54 828.71 800.41 3.54
Depreciation 9.25 7.69 20.29 35.36 25.76 37.27 35.36 25.76 37.27
PBT 209.49 155.30 34.89 793.35 774.65 2.41 793.35 774.65 2.41
TAX 50.63 38.39 31.88 201.71 194.96 3.46 201.71 194.96 3.46
Deferred Tax 0.97 0.05 1840.00 3.75 2.55 47.06 3.75 2.55 47.06
PAT 158.86 116.91 35.88 591.64 579.69 2.06 591.64 579.69 2.06
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 52.25 59.18 -11.71 48.93 54.06 -9.48 48.93 54.06 -9.48
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..